Scientists have moved a step closer to correcting
some unhealthy gene mutations with diet, according to a new research report
appearing in the April 2012 issue of the journal Genetics.
Researchers from the
University of California, Berkeley, determined variations and responses to
vitamin treatment in the human cystathionine beta synthase gene, which when
defective, causes the disease homocystinuria, an inherited metabolic disorder
sometimes treatable with vitamin B6.
After
the analysis, scientists correlated specific gene mutations with severity of
the disease, ranging from perfectly healthy and functional to severe and
untreatable. Although the current study focused on homocystinuria, testing the
effects of naturally occurring gene variations using surrogate organism
genetics can be applied to other inherited disorders, such as neural tube
defect, cleft palate, and blindness.
"The
era of personal genome sequences is upon us, but there is a growing gap between
the ability to sequence human genomes and the ability to understand the
significance of variation in genome sequences," said Jasper Rine, Ph.D.,
the principal investigator of this research in the Department of Molecular and
Cell Biology at the California Institute of Quantitative Biosciences at the
University of California, Berkeley. "This study demonstrates one way to
close the gap; the data separate gene variants into distinct classes, including
a group amenable to dietary intervention."
To make
their determination, scientists "swapped" the cystathionine beta
synthase gene of baker's yeast with the gene from humans to test which variants
were healthy, treatable, or untreatable with additional vitamin B6. As a
result, the study clarified the function of 84 DNA sequence variants in this
gene, which will help physicians more effectively treat patients based on their
particular genotypes. In addition, this approach opens doors for future studies
examining other human genes that similarly cross over between humans and yeast.
"We
may have the DNA sequence of the human genome, but we're still trying to figure
out what it means," said Mark Johnston, Editor-in-Chief of the journal
Genetics. "This study moves us a step closer toward better understanding
the genetic variability among people. More immediately, knowledge of these gene
mutations will help physicians prescribe treatment based on genotype rather
than outward symptoms or trial and error."
Source:
Genetics Society of America
No comments:
Post a Comment